|
|
Volumn 256, Issue 3, 2009, Pages 390-395
|
|
Reversible Pisa syndrome in patients with Parkinson's disease on dopaminergic therapy
a
|
|
Author keywords
Dopaminergic therapy; Parkinson's disease; Pysa syndrome
|
|
Indexed keywords
ANTIPARKINSON AGENT;
BENSERAZIDE PLUS LEVODOPA;
CARBIDOPA PLUS ENTACAPONE PLUS LEVODOPA;
CARBIDOPA PLUS LEVODOPA;
DOPAMINE RECEPTOR STIMULATING AGENT;
IODINE 123;
PERGOLIDE;
PRAMIPEXOLE;
ADULT;
AGED;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL ASSESSMENT;
CLINICAL FEATURE;
COMORBIDITY;
CONTROLLED STUDY;
DISEASE COURSE;
DRUG DOSE COMPARISON;
DRUG WITHDRAWAL;
DYSTONIA;
FEMALE;
HUMAN;
MALE;
PARKINSON DISEASE;
PISA SYNDROME;
PRIORITY JOURNAL;
SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;
VIDEORECORDING;
AGED;
AGED, 80 AND OVER;
BENSERAZIDE;
BENZOTHIAZOLES;
BRAIN;
CARBIDOPA;
DOPAMINE AGENTS;
DYSTONIA;
FEMALE;
HUMANS;
LEVODOPA;
MALE;
MIDDLE AGED;
PARKINSON DISEASE;
PERGOLIDE;
SEVERITY OF ILLNESS INDEX;
TIME FACTORS;
TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;
TROPANES;
|
|
EID: 67349151775
PISSN: 03405354
EISSN: 14321459
Source Type: Journal
DOI: 10.1007/s00415-009-0072-6 Document Type: Article |
|
Times cited : (67)
|
|
References (20)
|
